Abstracts - faqs.org

Abstracts

General interest

Search abstracts:
Abstracts » General interest

There's so much to see

Article Abstract:

Bausch & Lomb invented a new medicine, which can be used for the prevention of the disease called age related macular degeneration (ADM), called Prevision eye vitamin. The advantages of this product and some details of the product are presented.

Publisher: Reader's Digest Association, Inc.
Publication Name: Reader's Digest
Subject: General interest
ISSN: 0034-0375
Year: 2005
Ophthalmic goods, Ophthalmic Drugs, Eyewear industry, Ophthalmic agents, Bausch & Lomb Inc., BOL, Macular degeneration, Prevision (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Adderall XR

Article Abstract:

Adderall XR, a product of Shire U.S. Inc., is a new medication created for the ADHD. The results of the research conducted on this product are also mentioned. The precautions to be taken during the usage of this product are discussed.

Publisher: Reader's Digest Association, Inc.
Publication Name: Reader's Digest
Subject: General interest
ISSN: 0034-0375
Year: 2005
Psychotherapeutic Preparations, Pharmaceutical industry, Psychotropic drugs, Attention-deficit hyperactivity disorder, Attention deficit hyperactivity disorder, Shire US Inc., Adderall XR (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Product information, Drug therapy, Advertisement
Similar abstracts:
  • Abstracts: Charlize angel. There's something about Mira. Friend and lover
  • Abstracts: Mixed blessings. The star report
  • Abstracts: Meet the MythBusters. Serve yourself. Queasy rider
  • Abstracts: The genetic roots of alcoholism. The best medicine. Battle of the bulge: Obesity can be beaten
  • Abstracts: Lunesta. Humira
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.